Teaching hospital Program year 2025 Source: CMS Open Payments

University of Virginia Medical Cente

VA

CCN 490009 CMS hospital 16986

Open in the dashboard

General payments

$8,594,977

1,651 payments

Research payments

$108,045,187

9,153 payments

Through program year 2025, University of Virginia Medical Cente is reported as receiving $8,594,977 in general payments and $108,045,187 in research payments from drug and medical device manufacturers.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $1,073,955 261
2025 Research $16,829,257 1,871
2024 General $1,457,986 255
2024 Research $19,017,712 1,644
2023 General $1,085,901 220
2023 Research $15,007,580 1,178
2022 General $1,537,433 201
2022 Research $15,677,155 1,068
2021 General $961,860 214
2021 Research $13,789,824 1,236
2020 General $847,365 214
2020 Research $16,390,060 1,112
2019 General $1,630,477 286
2019 Research $11,333,599 1,044

Breakdown

Who paid General payments · program years 2019–2025
  1. Novo Nordisk AS $890,400 2 payments
  2. Tandem Diabetes Care, Inc. $887,263 79 payments
  3. Abbott Laboratories $443,888 26 payments
  4. Centerline Biomedical Inc. $400,578 5 payments
  5. Synthes GmbH $332,000 16 payments
  6. E.R. Squibb & Sons, L.L.C. $318,725 23 payments
  7. Exactech, Inc. $306,000 10 payments
  8. Alexion Pharmaceuticals, Inc. $285,039 71 payments
  9. Medical Device Business Services, Inc. $252,624 53 payments
  10. AstraZeneca Pharmaceuticals LP $200,602 59 payments
  11. Other $4,277,858 1,307 payments
What the payments were for General payments · program years 2019–2025
  1. Grant $2,382,075 240 payments
  2. Space rental or facility fees (teaching hospital only) $1,947,328 913 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,506,856 214 payments
  4. Royalty or License $1,066,844 18 payments
  5. Long term medical supply or device loan $638,526 39 payments
  6. Education $625,753 95 payments
  7. Charitable Contribution $308,504 29 payments
  8. Consulting Fee $46,140 11 payments
  9. Gift $38,003 24 payments
  10. Debt forgiveness $26,193 64 payments
  11. Other $8,755 4 payments
Products named General payments · program years 2019–2025
  1. t-slim insulin pump $873,013 49 payments
  2. FreeStyle Lite system $379,929 1 payment
  3. Iops Vascular Surgery $302,510 4 payments
  4. Iops Software Application $302,510 4 payments
  5. Iops Mobile Cart Vascular Surgery $302,510 4 payments
  6. Iops Vascular Surgery $272,232 3 payments
  7. Iops Vascular Surgery $272,232 3 payments
  8. Xenoview $134,766 1 payment
  9. Provision of products $99,438 3 payments
  10. Iops Mobile Cart Vascular Surgery $98,068 1 payment
  11. Other $3,394,744 1,227 payments

A payment can name more than one product, so these amounts overlap.

1,651 general · 9,153 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

A teaching hospital's total is institutional. It is money reported as going to the hospital itself, and it is kept separate from anything reported about the individual clinicians who work there — the two are never added together.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record